Building on promising work in melanoma [65], subsequent studies in the 1990s characterized cSCC as a T-cell-rich tumor, dominated by CD3+ and CD4+ lymphocytes, but provided little insight into their function [15,16,17]. This evidence concerns the gene CD4 and melanoma.